Search Within
文件类型
239-257-0
关键词:'239-257-0'
显示 1-21 共 21 条结果 关于 "239-257-0" 范围 技术文档
Calbiochem Biologics 33.2
90% by SDS-PAGE. M.W. 50,000.
Cat. No. 481413 10 mg €239
PhosphoDetect™ Hsp27 (pSer78/82) ELISA Kit
Format: 96-well plate
Assay range: 0 .1-10 ng/ml; Assay time: 4 .5 h
A quantitative sandwich
BRAND Katalog EN
Straight-bore 237
T-bore 237
Stoppers
Conical ground joint 240
Rubber 239
Silicone 239
Storage bottles 256, 257
Straight-bore stopcocks (one-way) 237
Sugar hydrometers
(saccharimeters, Brix
Bulletin - RATVS
al., Primer-directed enzymatic amplification of DNA with a thermostable DNA
polymerase. Science 239 (4839), 487-491 (1988).
Sambrook, J., et al. Molecular Cloning: A Laboratory Manual, third edition
Bulletin - MOUSEVS
al. Primer-directed enzymatic amplification of DNA with a thermostable DNA
polymerase. Science 239 (4839), 487-491 (1988).
Sambrook, J., et al. Molecular Cloning: A Laboratory Manual, third edition
Biologics 31.1
0.077 257 0.77 2. 6 7.7 26 77(mU)
Calbiochem Biologics 31.1
0.077 257 0.77 2. 6 7.7 26 77(mU)
FlowCellect™ MitoDamage Kit (100 Tests)
basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Wyllie AH, et al. Cell Death: The significance of apoptosis. Int Rev Cytol. 1980;68:251-
Katalog OHAUS
83032842 227
A71P6TN s veží 6kg 2g 240mm x 337mm 83032850 257
A71PH12N 12kg 2g 240mm x 337mm 83032844 227
A71P15TN s veží 15kg 5g 240mm x 337mm 83032852 257
A71P15N 15kg 5g 240mm x 337mm 83032845 227
A71P30N
Packaging portfolio for chemicals: A selection of Data Sheets
Schaltfläche 238:
Schaltfläche 121:
Schaltfläche 122:
Schaltfläche 123:
Schaltfläche 239:
Schaltfläche 209:
Schaltfläche 2011:
Schaltfläche 250:
Schaltfläche 2010:
Schaltfläche
Building blocks for peptide synthesis
X. Han, et al. (1997) J. Org. Chem., 62, 4307.
85. Y. M. Angell, et al. (2002) J. Peptide Res., 5, 239.
86. Y. Fujiwara, et al. (1994) Chem. Pharm. Bull., 42, 72
87. a) J.H. Jones & W.I. Ramage (1978)
Biologics 32.3: NF-kB Activation: A Link Between Chronic Inflammation and Cancer
Reacts with most
mammalian species and Xenopus. ELISA, FS, IB, IC, PS
Cat. No. ST1110 100 ml € 239
Anti-Myelin Basic Protein Mouse mAb (SMI-94)
Liquid, undiluted ascites. Immunogen used was purified
Chrombook (WEB-Version)
192, 238, 269
Amount of alkyl chains 214
Amphetamine compounds 276
Angiotensin I and II 257
Anisols 239
Antiepileptic drugs (AEDs) in serum 48
Application of LiChrolut® EN 54
Aqueous mobile phase
S&E Campaign Lab Tools - Tables for laboratory use
200 392
– 20 – 4 25 77 70 158 115 239 160 320 210 410
– 15 + 5 30 86 75 167 120 248 165 329
– 10 14 35 95 80 176 125 257 170 338
– 5 23 40 104
Katalog neoLab
. . . . .236
2-8480 . . . . . . . . . . . . . . . . .239
2-8482 . . . . . . . . . . . . . .
Perfection in every dimension - Inorganic Reagents catalog
1
.1
5
4
7
4
.0
1
0
0
M
u
lt
i-
el
em
en
t
st
an
d
ar
d
I
V
2
3
e
le
m
en
ts
, 1
0
0
0
m
g/
l
O
rd
. N
o
. 1
Perfección en todas sus dimensiones. Catálogo de reactivos inorgánicos
1
.0
94
93
.0
10
0
Es
tá
nd
ar
d
e
M
ul
tie
le
m
en
to
s X
I
pa
ra
lo
do
s d
e
de
pu
ra
do
ra
XP725 Antibody List 013M4793
y y y
238 Dystrophin D8043 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y
239 E2F1 E9026 1869 E2F1 NP_005216.1 P y n/d n/d
240 Anti Cy3+Cy5 C0992
241 E2F1 E8901 399489, 13555, 1869
XP725 Antibody List
y y y
238 Dystrophin D8043 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y
239 E2F1 E9026 1869 E2F1 NP_005216.1 P y n/d n/d
240 Anti Cy3+Cy5
241 E2F1 E8901 399489, 13555, 1869 E2F1
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
No.
Antibody
phospho-SHC (Tyr317) 15E11 H M WB M IgG1κ 100 µg 05-668
Anti-shc (phospho-Tyr 239/pTyr 240) M IgG 100 µg 04-312
Anti-shc/p66 (N-Terminus) M IgG 100 µg 04-313
Anti-shc/p66 (phospho-Ser
TLC Application compilation
In-situ evaluation with TLC/HPTLC scanner (Camag) UV 238 nm
TLC Application Note 239
Merck Millipore is
Inhibitor Sourcebook 3rd Edition
Martiny-Baron, G.M. et al. 1993. J. Biol. Chem. 268, 9194.
2. Marte, B.M., et al. 1994. Cell Growth Differ. 5, 239.
3. Gschwendt, M., et al. 1996. FEBS Lett. 392, 77.
4. Jirousek, M.R., et al. 1996. J. Med. Chem